Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 73.00% |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1,378.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.59% |
| Dec 31, 2025 | 2,482.74% |
| Sep 30, 2025 | 604.41% |
| Jun 30, 2025 | 124.58% |
| Mar 31, 2025 | -53.34% |
| Dec 31, 2024 | -87.16% |
| Sep 30, 2024 | -90.56% |
| Jun 30, 2024 | -377.22% |
| Mar 31, 2024 | 12.62% |
| Dec 31, 2023 | 1.06% |
| Sep 30, 2023 | -45.60% |
| Jun 30, 2023 | -46.20% |
| Mar 31, 2023 | -55.72% |
| Dec 31, 2022 | 234.57% |
| Sep 30, 2022 | -34.37% |
| Jun 30, 2022 | 1,798.73% |
| Mar 31, 2022 | -30.20% |
| Dec 31, 2021 | -249.76% |
| Sep 30, 2021 | -75.58% |
| Jun 30, 2021 | -100.87% |